The provided programs implements the EORTC Scoring System for low grade gliomas
as published in the scientific article: New validated prognostic models and
calculators in patients with low grade gliomas confirmed by central pathology
review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials. Under
review.
They allow the user to estimate the median progression free survival, median
survival , probability of progression free survival at 3 years, the probability
of survival at 5 years in patients with low grade gliomas based on 5 different
prognostic factors: treatment administered after surgery or biopsy, time since
first symptoms, presence of neurological deficit or neurologic score, tumor
histological type and tumor size.
Get access to the prognostic calculators here